Signal Point Hematology/Oncology, Inc. is a clinical research site located in Middletown, Ohio, United States 45042.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Signal Point Hematology/Oncology, Inc. has participated in 5 clinical trials.
Therapeutic areas: Small Cell Lung Cancer, Lung Cancer, Non-small-cell Lung Carcinoma.
Sponsors: CytRx, Genentech, Inc., Puma Biotechnology, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Signal Point Hematology/Oncology, Inc. has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Signal Point Hematology/Oncology, Inc. has 5 clinical trials on record. Their work covers Small Cell Lung Cancer, Lung Cancer, Non-small-cell Lung Carcinoma.
Yes — Signal Point Hematology/Oncology, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.